Literature DB >> 20209636

Oligomeric alpha-synuclein and its role in neuronal death.

David R Brown1.   

Abstract

Alpha-synuclein is a natively unfolded protein associated with a number of neurodegenerative disorders that include Parkinson's disease. In the past, research has focused on the fibrillar form of the protein. Current research now indicates that oligomeric alpha-synuclein is the form of the protein most likely to causes neuronal death. Recent research has suggested that a unique oligomer associated with the copper binding capacity of the protein is the neurotoxic form of the protein. This review looks at the evidence for this possibility.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20209636     DOI: 10.1002/iub.316

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  23 in total

1.  α-Synuclein oligomers oppose long-term potentiation and impair memory through a calcineurin-dependent mechanism: relevance to human synucleopathic diseases.

Authors:  Zane S Martin; Volker Neugebauer; Kelly T Dineley; Rakez Kayed; Wenru Zhang; Lindsay C Reese; Giulio Taglialatela
Journal:  J Neurochem       Date:  2011-11-28       Impact factor: 5.372

Review 2.  Concepts of scientific integrative medicine applied to the physiology and pathophysiology of catecholamine systems.

Authors:  David S Goldstein
Journal:  Compr Physiol       Date:  2013-10       Impact factor: 9.090

3.  BRI2 ectodomain affects Aβ42 fibrillation and tau truncation in human neuroblastoma cells.

Authors:  M Del Campo; C R Oliveira; W Scheper; R Zwart; C Korth; A Müller-Schiffmann; G Kostallas; H Biverstal; J Presto; J Johansson; J J Hoozemans; C F Pereira; C E Teunissen
Journal:  Cell Mol Life Sci       Date:  2014-10-22       Impact factor: 9.261

4.  Interplay between desolvation and secondary structure in mediating cosolvent and temperature induced alpha-synuclein aggregation.

Authors:  V L Anderson; W W Webb; D Eliezer
Journal:  Phys Biol       Date:  2012-08-29       Impact factor: 2.583

5.  Cu(II) promotes amyloid pore formation.

Authors:  Hangyu Zhang; Jean-Christophe Rochet; Lia A Stanciu
Journal:  Biochem Biophys Res Commun       Date:  2015-06-28       Impact factor: 3.575

6.  The prion hypothesis of Parkinson's disease.

Authors:  Yaping Chu; Jeffrey H Kordower
Journal:  Curr Neurol Neurosci Rep       Date:  2015-05       Impact factor: 5.081

7.  C-terminal part of α-synuclein mediates its activity in promoting proliferation of dopaminergic cells.

Authors:  Juanjuan Yin; Junyan Han; Chen Zhang; Qiu-Lan Ma; Xin Li; Furong Cheng; Guangwei Liu; Yaohua Li; Kenji Uéda; Piu Chan; Shun Yu
Journal:  J Neural Transm (Vienna)       Date:  2011-02-18       Impact factor: 3.575

8.  Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brains.

Authors:  Douglas G Walker; Lih-Fen Lue; Charles H Adler; Holly A Shill; John N Caviness; Marwan N Sabbagh; Haruhiko Akiyama; Geidy E Serrano; Lucia I Sue; Thomas G Beach
Journal:  Exp Neurol       Date:  2012-11-28       Impact factor: 5.330

9.  Exploring the Transition of Human α-Synuclein from Native to the Fibrillar State: Insights into the Pathogenesis of Parkinson's Disease.

Authors:  Naveed Ahmad Fazili; Aabgeena Naeem
Journal:  J Fluoresc       Date:  2016-06-30       Impact factor: 2.217

Review 10.  Recent advances in α-synuclein functions, advanced glycation, and toxicity: implications for Parkinson's disease.

Authors:  Erika Guerrero; P Vasudevaraju; Muralidhar L Hegde; G B Britton; K S Rao
Journal:  Mol Neurobiol       Date:  2012-08-26       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.